Streetbeat News

SNDL

SNDL Inc.

https://www.sndlgroup.com

Industry

Drug Manufacturers - Specialty & Generic

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

Open

1.97

Mkt cap

518M

Volume

1.5M

High

1.98

P/E Ratio

-6.50

52-wk high

2.93

Low

1.94

Div yield

N/A

52-wk low

1.30

Numerous companies are scheduled to report their earnings on March 21, 2024, covering a wide range of industries from technology to healthcare. The reports include a mix of expected quarterly earnings and losses, with notable companies such as Welltower, Academy Sports, Exscientia, Direxion Daily CSI China Internet Index Bull 2X Shares, and Winnebago Industries among those reporting before the bell. After the bell, companies like Lululemon Athletica, Nike, FedEx, and Intellicheck will report, providing insights into their financial health and performance.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 10:15 am

SNDL reported Q4 sales of $182.55M, surpassing the $178.85M estimate, marking a 2.07% beat but reflecting a 24.07% decrease from the previous year's $240.41M.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:11 am

Marijuana stocks experienced significant gains on a bullish Monday, with Greenlane Holdings leading the surge at 31.82% increase. Notable gainers include Heritage Cannabis, Canopy Growth, and Aurora Cannabis among others. Conversely, a few companies like Rocky Mountain High and Global Compliance faced declines.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 15, 2024, with notable gainers including CordovaCann, Global Hemp Group, and Canopy Growth, among others. Conversely, Australis Capital led the losers with a dramatic drop. The movements reflect varying investor sentiments and market dynamics within the cannabis sector.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 9:30 pm

DEA officials are reportedly at odds with the Biden administration over the push to reschedule marijuana from Schedule I to Schedule III, despite recommendations from the U.S. Health and Human Services (HHS). The DEA is concerned about the increased THC potency and questions the medical value of cannabis. The move to Schedule III would allow state cannabis businesses federal tax deductions and ease research barriers but wouldn't federally legalize marijuana. The timeline for the DEA's decision is uncertain, but it's expected to be completed this year. The Biden administration's cannabis policies have been positively received by the public, according to recent polls.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 5:21 pm

Marijuana stocks experienced significant movement with Global Hemp Group, SOL Glb Inv, and others posting gains, while Item 9 Labs, Indiva, and additional companies saw declines. Notably, Neptune Wellness Solns, Corbus Pharmaceuticals, Scotts Miracle Gro, OrganiGram Holdings, Cara Therapeutics, Village Farms Intl, Canopy Growth, GrowGeneration, and SNDL were among the NASDAQ and NYSE listed companies affected.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 9:30 pm

A coalition of law enforcement leaders has requested President Biden to reclassify marijuana from a Schedule I to a Schedule III substance under the Controlled Substances Act, citing the shift in public opinion and the discrepancy between state and federal laws. This move is supported by Democratic Senators and aligns with recommendations from the Department of Health and Human Services to the DEA.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 3:31 pm

Cannabis stocks experienced significant movements on February 20, 2024, with Aurora Cannabis leading the gainers with a 790.59% increase, while GreenGro Technologies led the losers with a 99.00% decrease. Other notable movements include AusCann Group and Maple Leaf Green World with substantial gains, and SNDL, Canopy Growth, and Tilray Brands among the notable losers.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 9:30 pm

Negotiations over the Safe Banking Act, specifically section 10 which addresses protections for gun shops and relates to the Operation Choke Point program, are nearing completion according to Rep. Blaine Luetkemeyer. This section has been a point of contention but is close to being finalized, with support from both sides of the aisle.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 3:52 pm

The article provides a detailed list of cannabis stock gainers and losers for February 13, 2024, highlighting significant movements in the market. Notable gainers include AusCann Group Holdings with a 292.86% increase, while iAnthus Capital Holdings led the losers with a 28.57% decrease. The list includes companies from various exchanges, indicating a broad impact across the cannabis sector.

Portfolio Pulse from Benzinga Insights

February 13, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.